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SUMMARY 
Three analogues of LH-RH in which Dextrarotatory amino acids were substituted 
for the Gly6, and two additional analogues in which the Leu7 residue was also modified, 
were subjected to enzymic preparations derived from rat hypothalamus or anterior 
pituitary. These enzymes, known to cleave LH-RH, preferentially at the Gly6-Leu7 
position, proved less effective in degrading all the analogues tested. Among the Gly6 
substituted analogues, [ D-Trp6] LH-RH, having the highest LH-releasing activity, was 
most resistant to degradation. Additional modification, at position 7, although 
rendering the analogues immune to enzymic attack, did not further enhance their 
biological potency. These data suggest that degradation of LH-RH is a physiological 
determinant of its biological activity and has therefore to be considered with on 
designing new, potent analogues of the hormone. 
Luteinizing hormone-releasing hormone (LH-RH) can be rapidly degraded by 
potent enzymes present in rat hypothalamus and anterior pituitary (1,2,3). These 
enzymes cleave the decapeptide, pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly NHg 
preferentially at the Gly6 - Leu7 bond (1). As the degrading activity is present at the 
sites of release (hypothalamus) and of action (pituitary) of LH-RH, it may have a 
physiological role in the fine control of the amount of the hormone at the receptor site, 
Several synthetic analogues of LH-RH, modified at positions Gly6 and Leu7 have been 
reported to possess enhanced luteinizing hormone-releasing activities in in vitro -- 
systems (4,5,6). The relationship between the resistance to LH-RH -degrading 
enzymes and the increased biological potency of these analogues is dealt with in this 
study. 
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Table 1. Parameters of LH-RH degradation by pituitary-enzyme preparation 
Enzyme LH-RH recovered 
(u g protein) ox) 
LH-RH degraded 
(%) 
Specific activity 
0 560 i 15.0 0 0 
50 310 i 37.8 44.6 f 9.4 147.1 
100 200 a 20.8 64.3 rt 6.2 180.0 
200 133 i 7.2 76.2 f 3.9 185.6 
560 ng of LH-RH were exposed to various doses of enzyme, in a final volume of 1 ml, 
for 20 min at 37OC. The reaction was terminated by placing the reaction tubes in a 
boiling-water bath for 3 min. Tubes were spun for 10 min at 3000 x g and aliquots 
taken for RIA of LH-RH. Specific activity of the enzyme was defined as the amount of 
degraded LH-RH (ng) per log protein @ g) of the enzymic preparation. Mean + SEM 
for 6 determinations. 
MATERIALS AND METHODS 
LH-RH and analogues. LH-RH was supplied by Hoechst, A. G., (Frankfurt); 
[ D-LeuG] LH-RH, [D-Ala”] LH-RH, [ D-Leu’, (@-Me) Leu7] LH-RH and [ D-~rp6] 
LH-RH were a kind gift of Dr. D. Coy, while [ D-AlaG, (N”-Me) Zeus] LH-RH was 
received from Dr. W. Vale. 
Enzyme preparation. LH-RH - degrading enzyme was prepared as described 
previously (1). Briefly, medial-basal-hypothalami from 5 rats (about 8 mg each) or 5 
anterior pituitaries (about 9 mg each), were detached immediately after decapitation 
and immersed in a Thomas homogenizing vessel containing 1 ml of phosphate-buffered 
saline (PBS, pH 6.9). The tissue was homogenized (10 strokes) by a teflon pestle and 
spun for 10 min at 17,000 x g (Servall RC-2, rotor head SW 24). The resulting super- 
natant fraction was made up to the concentration of 30 mg wet weight/ml. Protein 
content of the preparation was determined by the Lowry procedure (7). 
Degradation reaction. 500 ng of LH-RH or of an analogue were subjected, in a 
final volume of 1 ml of PBS, to enzyme preparations derived from 3, 1.5 and 0.75 mg 
of tissue (corresponding to about 200, 100 and 50 )J g protein, respectively). The 
reaction, lasting for 20 min at 37OC, was terminated by placing the tubes in a boiling- 
water bath for 3 min. Heat resistant polypropylene tubes were used, as LH-RH tends 
to adsorb to glass. 
Determination of LH-RH and Its analogues. Tubes containing LHRH or 
analogues were spun for 10 min at 3000 x g and aliquots of the supernatant were 
taken for radioimmunoassay (RIA). The RIA system for LH-RH has been described 
at length elsewhere (8). Separate standard curves were constructed for each ana- 
logue. Results were evaluated using Student’s t-test. 
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Table 2. Degradation of LH-RH analogues by LH-RH - degrading enzymes of rat 
hypothalamus and pituitary 
Enzyme source 
Hypothalamus Anterior pituitary 
Analogues % degradation % degradation 
[D-Ala’] LH-RH 68.4 f 5.3 (12) 82.2 * 4. 0 (13) 
[ D-Leu’] LH-RH 54.1 f 3.0 (21) 58.8 f 4. 8 (18) 
[ D-Trp6] LH-RH 12. 0 f 4.1 (23) 17. 7 f 4.9 (25) 
[D-Ala’, (No-Me) Lsu7] LH-RH 0 (21) 0 (9) 
LH-RH and analogues (500 ng) were exposed to enzyme preparations for 20 min at 
37OC, as described in Table 1 and in the text. LH-RH degradation is defined as loo%, 
and the extent of analogue degradation is given as percent f SEM of that of LH-RH. 
Value in brackets indicates number of determinations. 
RESULTS 
Exposure of LH-RH to increasing amounts of enzymic preparations derived 
from rat hypothalamus or anterior pituitary results in increasing degradation of the 
hormone (see Table 1 for pituitary enzyme). Under the conditions of the reaction 
i. e. 20 min incubation at 37OC with pituitary preparations corresponding to 100 p g 
protein, about 36% of 500 ng of LH-RH can be recovered (Table 2). The extent to 
which LH-RH is degraded is arbitrarily defined as 100%; analogue degradation under 
the same conditions is expressed relatively to that of LH-RH. Analogues modified at 
the Gly6 or the Gly6 -Leu7 residues have a higher resistance to the LH-RH - degrad- 
ing enzymes (Table 2); the relative resistance of the analogues is: [D-Ala’, @-Me) 
Leu7] ‘LH-RH>[ D-Trp6] LH-RH > [ D-Leu’] LH-RH> [ D-Ala’] LH-RH > LH-RH. 
[D-J&u’, @-Me) Zeus] LH-RH is as resistant as [ D-Ala’, (No-Me) Leu7J LH-RH to 
enzymic attack. 
DTSCUSSION 
The factors determining the biological potencies of hormones and drugs include 
their affinities to their respective receptors and their local concentration at their 
target-sites; the latter, in turn, is dependent on the rate of clearance and the elimina- 
490 
Vol. 74, No. 2, 1977 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
tion by enzymes on the route to, and at the site of action. Thus, information about the 
relative resistance of LH-RH analogues to enz,ymic degradation may aid investigators 
in synthetizing substances possessing enhanced biological activity. We, therefore, 
subjected LH-RH, [D-Ala’] LH-RH, [ D-Leu’] LH-RH, [ D-Trp’] LH-RH, [D-Ala’, 
(No-Me) Leu7] LH-RH and [ D-Leu’, @.-Me) Leu7] LH-RH to enzymic preparations 
derived from rat hypothalamus or anterior pituitary. 
From the results shown above, it may be concluded that a correlation exists 
between the increased biological potencies of LH-RH analogues and their resistance to 
enzymic degradation. Thus, the least active analogue (5), [D-Ala’] LH-RH, is also 
the most susceptible, while [ D-Trp6] LH-RH, highly resistant to enzymic cleavage, 
has superior biological potency (5). [D-Ala’, (No-Me) Leu7] LH-RH, however, is 
exceptional in that, though immune to enzymic attack, it is only as active as [D-Ala’] 
LH-RH (4,6). This discrepancy may stem from impaired interaction of the analogue 
with its receptor; the No-methylic group may interfere with the binding to, or with the 
triggering of the receptor. 
Acknowledgements 
We are grateful to Miss N. Ben-Aroya for technical assistance and to Mr. S. 
Yossef for devoted animal care. The work was supported by a grant of the Ford 
Foundation and the Population Council Inc., N. Y., to Dr. H. R Lindner, whom we 
thank for his interest in this study. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
REFERENCES 
Koch, Y., Baram, T., Chobsieng, P. and Fridkin, M., Biochem. Biophys. 
Res. Cornmum, 6l.- 95 (1974). 
Griffiths, E. C. ~ Hooper, K. C. ~ Jeffcoate, S. L. and Holland, D. T., Acta 
., 7J 435 (1974). Endocr 
Kochman, K., Kerdelhue, B., Zor, U. and Jutisz, M., FEBS Lett., 50- 190 
(1975). 
Monahan, M.W., Amoss, M.S., Anderson, H.A. and Vale, W., Biochemistry, 
X2- 4616 (1973). 
Coy, D. H., Vilchez-Martinez, J.A., Coy, E.J. and Schally, A.V. p J. Med. 
., l9- 423 (1976). Chem 
Ling, N. and Vale, W., Biochem. Biophys. Res. Commun., 9 801 (1975). 
Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and Randall, R J., J. Biol. 
Chem -- J 193. 265 (1951). 
Koch, Y., Wilchek, M., Fridkin, M., Chobsieng, P., Zor, U. and Lindner, 
H. R, Biochem. Biophys. Res. Commun., 5 616 (1973). 
491 
